Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 691 AL 705

Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism

Brooks DJ.

Neurotherapeutics. 2021 Apr;18(2):753-771. doi: 10.1007/s13311-020-00994-4. Epub 2021 Jan 11.

α-Synuclein and neuronal membranes: Conformational flexibilities in health and disease

Bozelli JC Jr, Kamski-Hennekam E, Melacini G, Epand RM.

Chem Phys Lipids. 2021 Mar;235:105034. doi: 10.1016/j.chemphyslip.2020.105034. Epub 2021 Jan 9.

The potential of noisy galvanic vestibular stimulation for optimizing and assisting human performance

Lajoie K, Marigold DS, Valdés BA, Menon C.

Neuropsychologia. 2021 Feb 12;152:107751. doi: 10.1016/j.neuropsychologia.2021.107751. Epub 2021 Jan 9.

Therapeutic potential of ATP-sensitive potassium channels in Parkinson's disease

Zhao S, Wang M, Ma Z.

Brain Res Bull. 2021 Apr;169:1-7. doi: 10.1016/j.brainresbull.2021.01.003. Epub 2021 Jan 9.

Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews

Mentis AA, Dardiotis E, Efthymiou V, Chrousos GP.

BMC Med. 2021 Jan 13;19(1):6. doi: 10.1186/s12916-020-01873-7.

Olfactory impairment as an early marker of Parkinson's disease in REM sleep behaviour disorder: a systematic review and meta-analysis

Lyu Z, Zheng S, Zhang X, Mai Y, Pan J, Hummel T, Hähner A, Zou L.

J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):271-281. doi: 10.1136/jnnp-2020-325361. Epub 2021 Jan 12.

Gait parameters of Parkinson's disease compared with healthy controls: a systematic review and meta-analysis

Zanardi APJ, da Silva ES, Costa RR, Passos-Monteiro E, Dos Santos IO, Kruel LFM, Peyré-Tartaruga LA.

Sci Rep. 2021 Jan 12;11(1):752. doi: 10.1038/s41598-020-80768-2.

In vitro and in vivo models for anti-amyloidosis nanomedicines

Kakinen A, Javed I, Davis TP, Ke PC.

Nanoscale Horiz. 2021 Feb 1;6(2):95-119. doi: 10.1039/d0nh00548g. Epub 2021 Jan 13.

Reactive Oxygen Species: Beyond Their Reactive Behavior

Tauffenberger A, Magistretti PJ.

Neurochem Res. 2021 Jan;46(1):77-87. doi: 10.1007/s11064-020-03208-7. Epub 2021 Jan 13.

Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?

Viktorinova A, Durfinova M.

Neurosci Lett. 2021 Feb 6;745:135627. doi: 10.1016/j.neulet.2021.135627. Epub 2021 Jan 10.

Ceruloplasmin Deamidation in Neurodegeneration: From Loss to Gain of Function

Zanardi A, Alessio M.

Int J Mol Sci. 2021 Jan 11;22(2):663. doi: 10.3390/ijms22020663.

Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review

Yang X, Ma Y, Xie H, Dong S, Rao G, Yang Z, Zhang J, Wu Q.

Curr Med Chem. 2021;28(31):6375-6394. doi: 10.2174/0929867328666210113170941.

Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease

Beach TG, Russell A, Sue LI, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Hidalgo T, Chiarolanza G, Mariner M, Scroggins A, Pullen J, Souders L, Sivananthan K, Carter N, Saxon-LaBelle M, Hoffman B, Garcia A, Callan M, Fornwalt BE, Carew J, Filon J, Cutler B, Papa J, Curry JR, Oliver J, Shprecher D, Atri A, Belden C, Shill HA, Driver-Dunckley E, Mehta SH, Adler CH, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Fietz M, Lue LF, Walker DG, Mizgerd JP, Serrano GE.

medRxiv [Preprint]. 2021 Jan 8:2021.01.07.21249410. doi: 10.1101/2021.01.07.21249410.

Role of luteolin in overcoming Parkinson's disease

Siddique YH.

Biofactors. 2021 Mar;47(2):198-206. doi: 10.1002/biof.1706. Epub 2021 Jan 14.

A scoping review of the nature of physiotherapists' role to avoid fall in people with Parkinsonism

Alatawi SF.

Neurol Sci. 2021 Sep;42(9):3733-3748. doi: 10.1007/s10072-020-05015-y. Epub 2021 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias